Drug metabolism in human liver microsomes assessed as 5-(5-((2-Hydroxycyclopentyl)methyl)-4,5,6,7-tetrahydropyrazolo-[1,5-a]pyrazin-3-yl)-7-methylimidazo[5,1-f][1,2,4]triazin-4(3H)-one diastereomer 1 formation at 20 uM after 1.5 hrs by UHPLC-UV-HRMS method
Drug metabolism in human liver microsomes assessed as 5-(5-((2-Hydroxycyclopentyl)methyl)-4,5,6,7-tetrahydropyrazolo-[1,5-a]pyrazin-3-yl)-7-methylimidazo[5,1-f][1,2,4]triazin-4(3H)-one diastereomer 2 formation at 20 uM after 1.5 hrs by UHPLC-UV-HRMS method